Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2641948rdf:typepubmed:Citationlld:pubmed
pubmed-article:2641948lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:2641948lifeskim:mentionsumls-concept:C1882687lld:lifeskim
pubmed-article:2641948lifeskim:mentionsumls-concept:C0034826lld:lifeskim
pubmed-article:2641948lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:2641948lifeskim:mentionsumls-concept:C0019409lld:lifeskim
pubmed-article:2641948lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:2641948lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:2641948lifeskim:mentionsumls-concept:C1516853lld:lifeskim
pubmed-article:2641948pubmed:issue3lld:pubmed
pubmed-article:2641948pubmed:dateCreated1990-10-17lld:pubmed
pubmed-article:2641948pubmed:abstractTextAccording to molecular biological and pharmacological criteria, rat heart membranes normally express only one muscarinic receptor subtype. The selective antagonists pirenzepine and AF-DX 116 bind to this receptor with a single affinity: low and high, respectively. We report here that an endogenous, intracellular factor alters the affinity of selective antagonists for muscarinic receptors in the heart. Thus, when the intracellular fluid is added back to rat heart membranes, both pirenzepine and AF-DX 116 bind to two receptor sites. Approximately 30% of the receptors bind pirenzepine with high affinity and AF-DX 116 with low affinity. Thus, while cardiac muscarinic receptors are coded for by a single mRNA and are therefore genetically homogeneous, the resulting receptor protein might behave like a mixture of receptor subtypes in intact tissues due to the influence of intracellular factors on receptor conformation.lld:pubmed
pubmed-article:2641948pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2641948pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2641948pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2641948pubmed:languageenglld:pubmed
pubmed-article:2641948pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2641948pubmed:citationSubsetIMlld:pubmed
pubmed-article:2641948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2641948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2641948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2641948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2641948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2641948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2641948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2641948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2641948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2641948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2641948pubmed:statusMEDLINElld:pubmed
pubmed-article:2641948pubmed:issn0149-046Xlld:pubmed
pubmed-article:2641948pubmed:authorpubmed-author:FryerA DADlld:pubmed
pubmed-article:2641948pubmed:authorpubmed-author:el-FakahanyE...lld:pubmed
pubmed-article:2641948pubmed:issnTypePrintlld:pubmed
pubmed-article:2641948pubmed:volume8lld:pubmed
pubmed-article:2641948pubmed:ownerNLMlld:pubmed
pubmed-article:2641948pubmed:authorsCompleteYlld:pubmed
pubmed-article:2641948pubmed:pagination127-32lld:pubmed
pubmed-article:2641948pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:meshHeadingpubmed-meshheading:2641948-...lld:pubmed
pubmed-article:2641948pubmed:year1989lld:pubmed
pubmed-article:2641948pubmed:articleTitleAn endogenous factor induces heterogeneity of binding sites of selective muscarinic receptor antagonists in rat heart.lld:pubmed
pubmed-article:2641948pubmed:affiliationDepartment of Pharmacology and Toxicology, School of Pharmacy, University of Maryland, Baltimore 21201.lld:pubmed
pubmed-article:2641948pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2641948pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2641948lld:pubmed